NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis
Advanced SearchBrowse by AnalyteBrowse by Pre-analytical FactorSearch SOPsSOP Compendiums

Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium

Description

This document in this compendium was contributed by the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium which is part of the Rare Diseases Clinical Research Network (RDCRN; https://www.rarediseasesnetwork.org/). RDCRN is focused on therapeutic developments for amyotrophic lateral sclerosis, frontotemporal dementia, primary lateral sclerosis, hereditary spastic paraplegia, and progressive muscular atrophy. This SOP is available from https://www.rarediseasesnetwork.org/cms/create/researchers/biorepository.

Sources

  • CReATe

SOPs

Title Version (Release Date) Source
BIOSPECIMEN COLLECTION SOP CReATe
Download all SOP documents of selected versions [1]

News and Announcements

  • New Articles on the GTEx Project are Now FREELY Available!
  • Just Published!
  • April 24, 2024: Biobanking for Precision Medicine Seminar
    • More...